pharmaphorum

JANUARY 3, 2023

A pharmacologist by training, Rawlins was the founding chairman of health technology assessment (HTA) agency NICE , leading the organisation from its inception in 1999 until 2013, and hired Sir Andrew Dillon to become the organisation’s founding chief executive.

Medicine 52

Medicine Side effects Safety Healthcare 52

Legacy MEDSearch

JUNE 15, 2023

The Cala kIQ System with TAPS therapy offers a non-invasive, non-pharmacologic solution with minimal side effects. Founded in 2014, the company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.

Patients 98

Patients Recruitment Pharmacology Management 98

European Pharmaceutical Review

JULY 5, 2022

There is an urgent need for more effective chemotherapy treatments with less severe toxicity and side effects. Irinotecan – also known by the brand name Campto/Camptosar ® (Pfizer Ltd.) – has proven to be an effective chemotherapy agent against several types of gastrointestinal cancer. Camptosar prescribing information.

Patients 104

Patients Food and Drug Administration Side effects Safety 104

pharmaphorum

JANUARY 13, 2023

” NICE warned that potential recipients of statins need to be carefully assessed as the drugs have potential side effects such as myopathy and muscle pains, and stressed that they should not be viewed as a substitute to lifestyle changes such as a healthier diet and more exercise.

Side effects 52

Side effects Patients Doctors Medical 52

Celeritas

NOVEMBER 21, 2022

They only partially impact the target areas and have damaging side effects in adjacent regions. Gold nanowires further positively impact key organ transplant functions – synapse formation and stem cell differentiation – all without using growth factors, which cause negative side effects. 2014; 2 (11):1584–1593. [18]

Engineering 52

Engineering Transportation Side effects Networking 52

European Pharmaceutical Review

AUGUST 15, 2024

1 The cancer is a slow-growing but potentially life-threatening B-cell malignancy, in which increased activation of B-cell receptor signalling pathways leads to overgrowth of lymphocytes in bone marrow and other disease compartments. About the author Dr Mehrdad Mobasher, MPH, is the Chief Medical Officer for Hematology at BeiGene.

Safety 52

Safety Patients Medical Medicine 52

Pharmaceutical Technology

NOVEMBER 30, 2022

In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. Novo Nordisk is another company leading the charge in this field. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Medical 105

Medical Manufacturing Insurance Side effects 105